Medical weight loss helps treat insulin resistance, regulate appetite, support blood sugar balance, preserve muscle, and reduce metabolic resistance
PIONEER PLUS was therefore designed to evaluate the efficacy, safety, and tolerability of oral semaglutide at doses of 25 mg and 50 mg once daily, compared with the 14 mg once-daily dose that is already in clinical use. Primary outcome measures included change in A1C from baseline to week 52 and from baseline to week 68
Unlike traditional anti-ulcer drugs like cimetidine or famotidine, BPC 157 demonstrates consistent protective effects against various causes of mucosal injury, such as stress or alcohol consumption
Telehealth has modernized this process, making it much easier to find and maintain your ideal dose
They are not a weight loss solution and are not appropriate for patients who are significantly overweight or who have certain medical conditions